Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Polat Dunya, Cansu; Yalçın, Gizem yağmur; Kürtüncü, Murat; ERAKSOY, MEFKURE; Tulek, Zeliha

doi:10.4274/tnd.2021.63444

Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Gizem Yağmur Yalçın, (İstanbul Üniversitesi-Cerrahpaşa, Florence Nightingale Hemşirelik Fakültesi, İstanbul, Türkiye)

Cansu Polat Dünya, (İstanbul Üniversitesi-Cerrahpaşa, Florence Nightingale Hemşirelik Fakültesi, İstanbul, Türkiye)

Zeliha Tülek, (İstanbul Üniversitesi-Cerrahpaşa, Florence Nightingale Hemşirelik Fakültesi, İstanbul, Türkiye)

Murat Kürtüncü, (İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Nöroloji Anabilim Dalı, İstanbul, Türkiye)

Mefküre ERAKSOY (İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Nöroloji Anabilim Dalı, İstanbul, Türkiye)

Türk Nöroloji Dergisi

6 0

Yıl: 2021 Cilt: 27 Sayı: Özel Sayı 1 Sayfa Aralığı: 31 - 39 Metin Dili: İngilizce DOI: 10.4274/tnd.2021.63444 İndeks Tarihi: 20-01-2022

Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Öz:

Objective: The coronavirus disease-2019 (COVID-19) pandemic can increase anxiety and depression in patients with multiple sclerosis (PwMS). This study aimed to evaluate the predictors of anxiety and depression in PwMS during the COVID-19 pandemic and compare it with the general population (GP). Materials and Methods: The study was conducted in an MS clinic in Istanbul University Istanbul Faculty of Medicine. Data were collected online using a form including sociodemographics and questions on COVID-19-related knowledge and the hospital anxiety and depression scale. Results: This study included 800 participants (GP: 421, MS: 379). Anxiety (42.3% vs. 32.2%, p=0.002) and depression (53.9% vs. 39.6%, p<0.001) were more common, COVID-19-related knowledge was lower (9.1±1.5 vs. 9.9±1.2, p<0.001), and rate of COVID-19 infection was higher (15.4% vs. 6.9%, p<0.001) in the GP than PwMS. Among other factors, COVID-19-related knowledge was a common predictor of anxiety and depression in both GP and MS groups [odds ratio (OR): 0.8, 95% confidence interval (CI) 0.7-0.9, p=0.007 and OR: 0.7, 95% CI 0.7-0.9, p=0.020, for anxiety; OR: 0.7, 95% CI 0.7-0.9, p=0.001 and OR: 0.8, 95% CI 0.7-1.0, p=0.023 for depression, respectively]. Conclusion: This study revealed that PwMS have less anxiety and depression than the GP. Our study shows the importance of COVID-19-related knowledge and the need for psychological support during the pandemic.

Anahtar Kelime:

COVID-19 Döneminde Multipl Sklerozlu Hastaların Anksiyete ve Depresyon Düzeylerinin Değerlendirilmesi: Genel Popülasyon ile Karşılaştırılması

Öz:

Amaç: Koronavirüs hastalığı-2019 (COVID-19) pandemisi multipl skleroz (MS) hastalarında anksiyete ve depresyonu artırabilir. Bu çalışmanın amacı COVID-19 pandemisi sürecinde MS hastalarında anksiyete ve depresyonu değerlendirmek, yordayıcılarını belirlemek ve genel popülasyon (GP) ile karşılaştırmaktır. Gereç ve Yöntem: Çalışma İstanbul Üniversitesi İstanbul Tıp Fakültesi MS kliniğinde yürütüldü. Veriler, sosyodemografik özellikleri, COVID-19 bilgi düzeyini ve hastane anksiyete ve depresyon ölçeğine ilişkin soruları içeren bir form ile online olarak toplandı. Bulgular: Çalışmaya 800 katılımcı (GP: 421, MS: 379) dahil edildi. Anksiyete (GP: %42,3 vs. MS: %32,2, p=0,002) ve depresyon (GP: %53,9 vs. MS: %39,6, p<0,001) MS hastalarında genel popülasyona kıyasla daha düşük bulundu. COVID-19 bilgisi ise daha yüksekti (GP: 9,1±1,5’e vs. MS: 9,9±1,2, p<0,001). COVID-19 enfeksiyonu geçirme oranı daha düşüktü (GP: %15,4’e vs. %6,9, p<0,001). Diğer faktörlerin yanı sıra, COVID-19 hakkında bilgi düzeyi hem GP hem de MS gruplarında anksiyete ve depresyonun ortak bir yordayıcısıdır [anksiyete için odds oranı (OR): 0,8, %95 güven aralığı (GA): 0,7-0,9, p=0,007 ve OR: 0,7, %95 GA: 0,7-0,9, p=0,020, depresyon için; OR: 0,7, %95 GA: 0,7-0,9, p=0,001 ve OR: 0,8, %95 GA: 0,7-1,0, p=0,023). Sonuç: Çalışmamız MS hastalarının GP’ye göre daha az anksiyete ve depresyona sahip olduğunu ortaya koydu. Bu çalışma pandemi sürecinde COVID-19’a ilişkin bilgi düzeyinin önemini ve psikolojik destek ihtiyacının gerekliliğini göstermektedir.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. World health organization. Coronovirus disease pandemic. Access date 10.06.2021 Available from: https://www.who.int/emergencies/diseases/ novel-coronavirus-2019
2. Health TRM of platform of covid-19 information. Access date 10.06.2021 Available from: https://covid19.saglik.gov.tr/.
3. Kendzerska T, Zhu DT, Gershon AS, et al. The Effects of the Health System Response to the COVID-19 Pandemic on Chronic Disease Management: A Narrative Review. Risk Manag Healthc Policy 2021;14:575-584.
4. Capuano R, Altieri M, Bisecco A, et al. Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? J Neurol 2021;268:743-750.
5. Mantero V, Abate L, Balgera R, et al. Assessing the susceptibility to acute respiratory illness COVID-19-related in a cohort of multiple sclerosis patients. Mult Scler Relat Disord 2020;46:102453.
6. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
7. Aydemir Ö, Güvenir T, Kuey L, Kültür S. Validity and reliability of Turkish version of hospital anxiety and depression scale. Turk Psikiyatri Derg 1997;8:280-287.
8. Chiaravalloti ND, Amato MP, Brichetto G, et al. The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis. J Neurol 2021;268:1598-1607.
9. Özdin S, Bayrak Özdin Ş. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. Int J Soc Psychiatry 2020;66:504-511.
10. Wang Y, Di Y, Ye J, Wei W. Study on the public psychological states and its related factors during the outbreak of coronavirus disease 2019 (COVID-19) in some regions of China. Psychol Health Med 2021;26:13-22.
11. Nie XD, Wang Q, Wang MN, et al. Anxiety and depression and its correlates in patients with coronavirus disease 2019 in Wuhan. Int J Psychiatry Clin Pract 2021;25:109-114.
12. Mohr DC, Hart SL, Julian L, Tasch ES. Screening for depression among patients with multiple sclerosis: two questions may be enough. Mult Scler 2007;13:215-219.
13. Boeschoten RE, Braamse AMJ, Beekman ATF, et al. Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. J Neurol Sci 2017;372:331-341.
14. Alschuler KN, Roberts MK, Herring TE, Ehde DM. Distress and risk perception in people living with multiple sclerosis during the early phase of the COVID-19 pandemic. Mult Scler Relat Disord 2021;47:102618.
15. Pham T, Jetté N, Bulloch AGM, et al. The prevalence of anxiety and associated factors in persons with multiple sclerosis. Mult Scler Relat Disord 2018;19:35-39.
16. McKay KA, Tremlett H, Fisk JD, et al. Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology 2018;9:e1316-e1323.
17. Landfeldt E, Castelo-Branco A, Svedbom A, et al. The long-term impact of multiple sclerosis on the risk of divorce. Mult Scler Relat Disord 2018;24:145- 150.
18. Fisher PL, Salmon P, Heffer-Rahn P, et al. Predictors of emotional distress in people with multiple sclerosis: A systematic review of prospective studies. J Affect Disord 2020;276:752-764.
19. Motolese F, Rossi M, Albergo G, et al. The Psychological Impact of COVID-19 Pandemic on People With Multiple Sclerosis. Front Neurol 2020;11:580507.
20. Alnajashi H, Jabbad R. Behavioral practices of patients with multiple sclerosis during Covid-19 pandemic. PLoS One 2020 22;15:e0241103.
21. Shaygannejad V, Afshari-Safavi A, Hatef B. Assessment of mental health, knowledge, and attitude of patients with multiple sclerosis and neuromyelitis optica spectrum disorder in response to 2019 novel coronavirus. Neurol Sci 2021;42:2891-2901.
22. Ustun G. Determining depression and related factors in a society affected by COVID-19 pandemic. Int J Soc Psychiatry 2021;67:54-63.
23. Salari N, Hosseinian-Far A, Jalali R, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health 2020;16:57.
24. Shah SMA, Mohammad D, Qureshi MFH, Abbas MZ, Aleem S. Prevalence, Psychological Responses and Associated Correlates of Depression, Anxiety and Stress in a Global Population, During the Coronavirus Disease (COVID-19) Pandemic. Community Ment Health J 2021;57:101-110.
25. Smith L, Jacob L, Yakkundi A, et al. Correlates of symptoms of anxiety and depression and mental wellbeing associated with COVID-19: a crosssectional study of UK-based respondents. Psychiatry Res 2020;291:113138.
26. Mazza MG, De Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun 2020;89:594-600.
27. Costabile T, Carotenuto A, Lavorgna L, et al. COVID-19 pandemic and mental distress in multiple sclerosis: Implications for clinical management. Eur J Neurol 2021;28:3375-3383.
28. Farpour HR, Hoveidaei AH, Habibi L, Moosavi M, Farpour S. The impact of social media use on depression in multiple sclerosis patients. Acta Neurol Belg 2020;120:1405-1409.
29. Sahraian MA, Azimi A, Navardi S, Ala S, Naser Moghadasi A. Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis. Mult Scler Relat Disord 2020;46:102472.
30. Berger JR, Brandstadter R, Bar-Or A. COVID-19 and MS disease-modifying therapies. Neurol Neuroimmunol Neuroinflamm 2020;7:e761.

APA	Yalçın G, Polat Dunya C, Tulek Z, Kürtüncü M, ERAKSOY M (2021). Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population. , 31 - 39. 10.4274/tnd.2021.63444
Chicago	Yalçın Gizem yağmur,Polat Dunya Cansu,Tulek Zeliha,Kürtüncü Murat,ERAKSOY MEFKURE Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population. (2021): 31 - 39. 10.4274/tnd.2021.63444
MLA	Yalçın Gizem yağmur,Polat Dunya Cansu,Tulek Zeliha,Kürtüncü Murat,ERAKSOY MEFKURE Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population. , 2021, ss.31 - 39. 10.4274/tnd.2021.63444
AMA	Yalçın G,Polat Dunya C,Tulek Z,Kürtüncü M,ERAKSOY M Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population. . 2021; 31 - 39. 10.4274/tnd.2021.63444
Vancouver	Yalçın G,Polat Dunya C,Tulek Z,Kürtüncü M,ERAKSOY M Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population. . 2021; 31 - 39. 10.4274/tnd.2021.63444
IEEE	Yalçın G,Polat Dunya C,Tulek Z,Kürtüncü M,ERAKSOY M "Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population." , ss.31 - 39, 2021. 10.4274/tnd.2021.63444
ISNAD	Yalçın, Gizem yağmur vd. "Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population". (2021), 31-39. https://doi.org/10.4274/tnd.2021.63444

APA	Yalçın G, Polat Dunya C, Tulek Z, Kürtüncü M, ERAKSOY M (2021). Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population. Türk Nöroloji Dergisi, 27(Özel Sayı 1), 31 - 39. 10.4274/tnd.2021.63444
Chicago	Yalçın Gizem yağmur,Polat Dunya Cansu,Tulek Zeliha,Kürtüncü Murat,ERAKSOY MEFKURE Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population. Türk Nöroloji Dergisi 27, no.Özel Sayı 1 (2021): 31 - 39. 10.4274/tnd.2021.63444
MLA	Yalçın Gizem yağmur,Polat Dunya Cansu,Tulek Zeliha,Kürtüncü Murat,ERAKSOY MEFKURE Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population. Türk Nöroloji Dergisi, vol.27, no.Özel Sayı 1, 2021, ss.31 - 39. 10.4274/tnd.2021.63444
AMA	Yalçın G,Polat Dunya C,Tulek Z,Kürtüncü M,ERAKSOY M Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population. Türk Nöroloji Dergisi. 2021; 27(Özel Sayı 1): 31 - 39. 10.4274/tnd.2021.63444
Vancouver	Yalçın G,Polat Dunya C,Tulek Z,Kürtüncü M,ERAKSOY M Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population. Türk Nöroloji Dergisi. 2021; 27(Özel Sayı 1): 31 - 39. 10.4274/tnd.2021.63444
IEEE	Yalçın G,Polat Dunya C,Tulek Z,Kürtüncü M,ERAKSOY M "Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population." Türk Nöroloji Dergisi, 27, ss.31 - 39, 2021. 10.4274/tnd.2021.63444
ISNAD	Yalçın, Gizem yağmur vd. "Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population". Türk Nöroloji Dergisi 27/Özel Sayı 1 (2021), 31-39. https://doi.org/10.4274/tnd.2021.63444